Lanzamiento Enero 2027

Estudio de cohortes2021Financiado por la industriaCuestionario de frecuencia de consumoSin ajuste declarado por estilo de vidaAcceso abierto

Financiado en parte por AstraZeneca, GlaxoSmithKline, Sanofi, AFA Försäkring, Servier

Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study

Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, Lopez-Jaramillo P, Rohatgi P, Lakshmi PVM, Varma RP, Orlandini A, Avezum A, Wielgosz A, Poirier P, Almadi MA, Altuntas Y, Ng KK, Chifamba J, Yeates K, Puoane T, Khatib R, Yusuf R, Boström KB, Zatonska K, Iqbal R, Weida L, Yibing Z, Sidong L, Dans A, Yusufali A, Mohammadifard N, Marshall JK, Moayyedi P, Reinisch W, Yusuf S

BMJ (Clinical research ed.) · 273 citas

Etiquetas de revisión

Cuestionario de frecuencia de consumoFinanciado por la industriaSin ajuste declarado por estilo de vida

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio de cohortes (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte
Consumo medido con
Cuestionario de frecuencia de consumo

Quién lo pagó

Financiación
Financiado por la industria
Empresa
AstraZeneca
Empresa
GlaxoSmithKline
Empresa
Sanofi
Organización sin fines de lucro
Heart and Stroke Foundation of Canada
Gobierno
Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)
Universidad u hospital
Hamilton Health Sciences
Gobierno
Public Health Agency of Canada
Gobierno
International Development Research Centre
Gobierno
National Research Foundation
Gobierno
South Africa Netherlands research Programme on Alternatives in Development
Gobierno
Indian Council of Medical Research
Gobierno
Public Health Agency
Gobierno
Forskningsrådet för Arbetsliv och Socialvetenskap
Gobierno
Svenska Forskningsrådet Formas
Universidad u hospital
King Saud University
Empresa
AFA Försäkring
Gobierno
Ministério da Ciência, Tecnologia e Inovação
Gobierno
Vetenskapsrådet
Universidad u hospital
Universiti Kebangsaan Malaysia
Universidad u hospital
Universiti Teknologi MARA
Universidad u hospital
North-West University
Universidad u hospital
Universidad de La Frontera
Universidad u hospital
Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
Empresa
Servier
Universidad u hospital
Independent University, Bangladesh
Universidad u hospital
Serbian Academy of Sciences and Arts
Gobierno
Canadian Institutes of Health Research
Gobierno
Medical Research Council
Gobierno
Philippine Council for Health Research and Development
Universidad u hospital
Faculty of Community and Health Sciences, University of the Western Cape
Subvenciones
Canadian Institutes of Health Research (6566-04-18062); Canadian Institutes of Health Research (290/W-PURE/2008/0); Universiti Teknologi MARA (UKM-Hejim-Komuniti-15-2010); Universiti Kebangsaan Malaysia (15-2010); Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS) (6566-04-18062)

Según 30 financiadores declarados.

Publicación

Publicado
2021-07-14 · BMJ · vol. 374 · pág. n1554
Citado
370 citas · más que el 100% de estudios similares · 44.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
57 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC
Áreas de investigación
Consumer Attitudes and Food Labeling · Nutritional Studies and Diet · Nutrition and Health in Aging
Palabras clave
Inflammatory bowel disease, Prospective cohort study, Medicine, Inflammatory Bowel Diseases, Cohort study, Cohort, Internal medicine, Disease, Environmental health
MeSH
humans, colitis, ulcerative, crohn disease, proportional hazards models, prospective studies, causality, energy intake, adult, aged, middle aged, female, male, diet, western

35 autores

  • Neeraj Narula🇨🇦🇫🇷 · autor de correspondenciaPopulation Health Research Institute; Institut de Recherche en Santé Digestive; Hamilton Health Sciences; McMaster University
  • Emily C L Wong🇨🇦Population Health Research Institute; McMaster University
  • Mahshid Dehghan🇨🇦Population Health Research Institute; Hamilton Health Sciences; McMaster University
  • Andrew Mente🇨🇦Population Health Research Institute; Hamilton Health Sciences; McMaster University
  • Sumathy Rangarajan🇨🇦Population Health Research Institute; Hamilton Health Sciences; McMaster University
  • Fernando Tomas Lanas🇨🇱Universidad de La Frontera
  • Patricio López‐Jaramillo🇨🇴Universidad De Santander
  • Priyanka Rohatgi🇮🇳Apollo Hospitals
  • P. V. M. Lakshmi🇮🇳Post Graduate Institute of Medical Education and Research
  • Ravi Prasad Varma🇮🇳Health Action by People
  • Andrés Orlandini🇦🇷Estudios Clínicos Latinoamérica
  • Álvaro Avezum🇧🇷Hospital Alemão Oswaldo Cruz; Universidade de Santo Amaro
  • Andreas T. Wielgosz🇨🇦University of Ottawa
  • Paul Poirier🇨🇦Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval
  • Majid Abdularahman Almadi🇸🇦King Saud University
  • Yüksel Altuntaş🇹🇷Sağlık Bilimleri Üniversitesi; Şişli Etfal Eğitim ve Araştırma Hastanesi
  • Kien Keat Ng🇲🇾National Defence University of Malaysia
  • Jephat Chifamba🇿🇼University of Zimbabwe
  • Karen Yeates🇨🇦Queen's University
  • Thandi Rose Puoane🇿🇦University of the Western Cape
  • Rasha Khatib🇵🇸Birzeit University
  • Rita Yusuf🇧🇩🇺🇸Independent University, Bangladesh; Advocate Health Care
  • Kristina Bengtsson Boström🇸🇪University of Gothenburg
  • Katarzyna Zatońska🇵🇱Wroclaw Medical University
  • Romaina Iqbal🇵🇰Aga Khan University
  • Liu Weida🇨🇳Chinese Academy of Medical Sciences & Peking Union Medical College
  • Zhu Yibing🇨🇳Chinese Academy of Medical Sciences & Peking Union Medical College
  • Sidong Li🇨🇳Chinese Academy of Medical Sciences & Peking Union Medical College
  • Antonio Miguel L. Dans🇵🇭University of the Philippines Manila
  • Afzalhussein Yusufali🇦🇪Dubai Health Authority
  • Noushin Mohammadifard🇮🇷Isfahan University of Medical Sciences
  • John Kenneth Marshall🇨🇦Population Health Research Institute; McMaster University
  • Paul Moayyedi🇨🇦Population Health Research Institute; Hamilton Health Sciences; McMaster University
  • Walter Reinisch🇦🇹Medical University of Vienna
  • Salim Yusuf🇨🇦Population Health Research Institute; Hamilton Health Sciences; McMaster University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

To evaluate the relation between intake of ultra-processed food and risk of inflammatory bowel disease (IBD).

Design

Prospective cohort study.

Setting

21 low, middle, and high income countries across seven geographical regions (Europe and North America, South America, Africa, Middle East, south Asia, South East Asia, and China).

Participants

116 087 adults aged 35-70 years with at least one cycle of follow-up and complete baseline food frequency questionnaire (FFQ) data (country specific validated FFQs were used to document baseline dietary intake). Participants were followed prospectively at least every three years.

Main outcome measures

The main outcome was development of IBD, including Crohn's disease or ulcerative colitis. Associations between ultra-processed food intake and risk of IBD were assessed using Cox proportional hazard multivariable models. Results are presented as hazard ratios with 95% confidence intervals.

Results

Participants were enrolled in the study between 2003 and 2016. During the median follow-up of 9.7 years (interquartile range 8.9-11.2 years), 467 participants developed incident IBD (90 with Crohn's disease and 377 with ulcerative colitis). After adjustment for potential confounding factors, higher intake of ultra-processed food was associated with a higher risk of incident IBD (hazard ratio 1.82, 95% confidence interval 1.22 to 2.72 for ≥5 servings/day and 1.67, 1.18 to 2.37 for 1-4 servings/day compared with <1 serving/day, P=0.006 for trend). Different subgroups of ultra-processed food, including soft drinks, refined sweetened foods, salty snacks, and processed meat, each were associated with higher hazard ratios for IBD. Results were consistent for Crohn's disease and ulcerative colitis with low heterogeneity. Intakes of white meat, red meat, dairy, starch, and fruit, vegetables, and legumes were not associated with incident IBD.

Conclusions

Higher intake of ultra-processed food was positively associated with risk of IBD. Further studies are needed to identify the contributory factors within ultra-processed foods.

Study registration

ClinicalTrials.gov NCT03225586.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.